Plain-English translation of NCT05714124 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational registry study that tracks patients with liver tumors—either cancer that started in the liver or cancer that has spread there from elsewhere—who are being treated with embolization techniques. Embolization works by blocking blood flow to tumors to slow their growth or shrink them. The study follows patients over the short, medium, and long term to understand how well these different embolization approaches work and how patients recover.
Doctors use several different embolization techniques to treat liver tumors that cannot be removed by surgery, but they need better information about which approaches work best and how patients do over time. This study collects real-world data to help improve treatment outcomes and guide future decisions.
You likely qualify if…
You likely don't qualify if…
As a participant, you will follow your normal cancer treatment plan—you will not receive any additional experimental procedures or medications. The study collects information about your medical history, your embolization treatment, and your progress over time through follow-up visits and medical records. You will be monitored to see how well the treatment works, whether your tumor shrinks, and how your liver function and overall health change in the months and years after treatment.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Italy
Sponsor
IRCCS San Raffaele
Enrollment target
~580 participants
Started
May 2021
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Francesco De Cobelli, MD
IRCCS San Raffaele
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.